Pen-sharing poses a risk for transmission of blood-borne pathogens Hypoglycemia: Patients receiving Ozempic in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
What is the management approach for a patient with a history of type 2 diabetes or obesity, taking Semaglutide (GLP-1 receptor agonist), who develops supraventricular tachycardia (SVT)?
This means that, for some patients, Wegovy is now a more cost-effective GLP-1 treatment option for weight management
Trial highlights: - Weight reduction: Patients achieved up to ~24% mean body weight loss at 48 weeks
Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N
Sure, your doctor mentioned increased libido as a side effect of testosterone replacement therapy